Enrique Poradosu Net Worth & Insider Trades

Enrique Poradosu - Chief Science & Business Off, Nuvectis Pharma, Inc

As of March 28, 2023

What is Enrique Poradosu's Net Worth?

The current estimated net worth of Nuvectis Pharma, Inc's Chief Science & Business Off, Enrique Poradosu, is estimated to be about $12.38M . Enrique Poradosu owns about 1,373,819 units of Nuvectis Pharma, Inc common stock. In the last year at Nuvectis Pharma, Inc, Enrique Poradosu has sold an estimated value of $0 worth.

What is Enrique Poradosu's Past Insider Trading?

Enrique Poradosu's largest purchase order was 4,600 units , worth over $15.83K on February 8, 2022. In total, Enrique Poradosu has made about 5 transactions over a year of their time at Nuvectis Pharma, Inc. Enrique Poradosu usually trades in May, March, February, January and April, with the busiest year in 2022. The most recent transaction was a purchase order of 500 units , worth over $5.78K on March 28, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Enrique Poradosu

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Enrique Poradosu's' Mailing Address?

  • Mailing address is C/o Nuvectis Pharma, Inc. 1 Bridge Plaza Fort Lee NJ 07024 NJ

What are Nuvectis Pharma, Inc's Past Insider Trades?

Nuvectis Pharma, Inc's most recent insider trade came on August 16, 2023 by Ron Bentsur who bought 350 units worth $5.11K . In the last year, insiders at Nuvectis Pharma, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in July, with the busiest year in 2023 and 2022. The most active traders at the company are Ron Bentsur, Chairman & CEO,  Charles Mosseri-Marlio,  and Shay Shemesh, Chief Dev. & Ops. Officer .

Nuvectis Pharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...